Table of Contents

2019-2024 Global POC HbA1C Testing Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global POC HbA1C Testing Consumption 2014-2024
  • 2.1.2 POC HbA1C Testing Consumption CAGR by Region
• 2.2 POC HbA1C Testing Segment by Type
  • 2.2.1 Immunoassay
  • 2.2.2 Boronate Affinity
  • 2.2.3 Others
• 2.3 POC HbA1C Testing Consumption by Type
  • 2.3.1 Global POC HbA1C Testing Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global POC HbA1C Testing Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global POC HbA1C Testing Sale Price by Type (2014-2019)
• 2.4 POC HbA1C Testing Segment by Application
  • 2.4.1 Hospital & Clinics
  • 2.4.2 Diagnostic Laboratories
  • 2.4.3 Other
• 2.5 POC HbA1C Testing Consumption by Application
  • 2.5.1 Global POC HbA1C Testing Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global POC HbA1C Testing Value and Market Share by Application (2014-2019)
  • 2.5.3 Global POC HbA1C Testing Sale Price by Application (2014-2019)

3 Global POC HbA1C Testing by Players

• 3.1 Global POC HbA1C Testing Sales Market Share by Players
  • 3.1.1 Global POC HbA1C Testing Sales by Players (2017-2019)
  • 3.1.2 Global POC HbA1C Testing Sales Market Share by Players (2017-2019)
• 3.2 Global POC HbA1C Testing Revenue Market Share by Players
  • 3.2.1 Global POC HbA1C Testing Revenue by Players (2017-2019)
  • 3.2.2 Global POC HbA1C Testing Revenue Market Share by Players (2017-2019)
• 3.3 Global POC HbA1C Testing Sale Price by Players
• 3.4 Global POC HbA1C Testing Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global POC HbA1C Testing Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players POC HbA1C Testing Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 POC HbA1C Testing by Regions

• 4.1 POC HbA1C Testing by Regions
  • 4.1.1 Global POC HbA1C Testing Consumption by Regions
  • 4.1.2 Global POC HbA1C Testing Value by Regions
• 4.2 Americas POC HbA1C Testing Consumption Growth
• 4.3 APAC POC HbA1C Testing Consumption Growth
• 4.4 Europe POC HbA1C Testing Consumption Growth
• 4.5 Middle East & Africa POC HbA1C Testing Consumption Growth

5 Americas

• 5.1 Americas POC HbA1C Testing Consumption by Countries
  • 5.1.1 Americas POC HbA1C Testing Consumption by Countries (2014-2019)
  • 5.1.2 Americas POC HbA1C Testing Value by Countries (2014-2019)
• 5.2 Americas POC HbA1C Testing Consumption by Type
• 5.3 Americas POC HbA1C Testing Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC POC HbA1C Testing Consumption by Countries
  • 6.1.1 APAC POC HbA1C Testing Consumption by Countries (2014-2019)
  • 6.1.2 APAC POC HbA1C Testing Value by Countries (2014-2019)
• 6.2 APAC POC HbA1C Testing Consumption by Type
• 6.3 APAC POC HbA1C Testing Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe POC HbA1C Testing by Countries
  • 7.1.1 Europe POC HbA1C Testing Consumption by Countries (2014-2019)
  • 7.1.2 Europe POC HbA1C Testing Value by Countries (2014-2019)
• 7.2 Europe POC HbA1C Testing Consumption by Type
• 7.3 Europe POC HbA1C Testing Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa POC HbA1C Testing by Countries
  • 8.1.1 Middle East & Africa POC HbA1C Testing Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa POC HbA1C Testing Value by Countries (2014-2019)
• 8.2 Middle East & Africa POC HbA1C Testing Consumption by Type
• 8.3 Middle East & Africa POC HbA1C Testing Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 POC HbA1C Testing Distributors
• 10.3 POC HbA1C Testing Customer

11 Global POC HbA1C Testing Market Forecast

• 11.1 Global POC HbA1C Testing Consumption Forecast (2019-2024)
• 11.2 Global POC HbA1C Testing Forecast by Regions
  • 11.2.1 Global POC HbA1C Testing Forecast by Regions (2019-2024)
  • 11.2.2 Global POC HbA1C Testing Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global POC HbA1C Testing Forecast by Type
• 11.8 Global POC HbA1C Testing Forecast by Application

12 Key Players Analysis

• 12.1 Abbott
  • 12.1.1 Company Details
  • 12.1.2 POC HbA1C Testing Product Offered
  • 12.1.3 Abbott POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Abbott News
• 12.2 Roche
  • 12.2.1 Company Details
  • 12.2.2 POC HbA1C Testing Product Offered
  • 12.2.3 Roche POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Roche News
• 12.3 Bio-Rad
  • 12.3.1 Company Details
  • 12.3.2 POC HbA1C Testing Product Offered
  • 12.3.3 Bio-Rad POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Bio-Rad News
• 12.4 Siemens
  • 12.4.1 Company Details
  • 12.4.2 POC HbA1C Testing Product Offered
  • 12.4.3 Siemens POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Siemens News
• 12.5 GREEN CROSS MEDIS
  • 12.5.1 Company Details
  • 12.5.2 POC HbA1C Testing Product Offered
  • 12.5.3 GREEN CROSS MEDIS POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 GREEN CROSS MEDIS News
• 12.6 Trinity Biotech
  • 12.6.1 Company Details
  • 12.6.2 POC HbA1C Testing Product Offered
  • 12.6.3 Trinity Biotech POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Trinity Biotech News
• 12.7 HUMAN Diagnostics
  • 12.7.1 Company Details
  • 12.7.2 POC HbA1C Testing Product Offered
  • 12.7.3 HUMAN Diagnostics POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 HUMAN Diagnostics News
• 12.8 PTS Diagnostics
  • 12.8.1 Company Details
  • 12.8.2 POC HbA1C Testing Product Offered
  • 12.8.3 PTS Diagnostics POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 PTS Diagnostics News
• 12.9 Erba Diagnostics
  • 12.9.1 Company Details
  • 12.9.2 POC HbA1C Testing Product Offered
  • 12.9.3 Erba Diagnostics POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Erba Diagnostics News
• 12.10 EKF Diagnostics
  • 12.10.1 Company Details
  • 12.10.2 POC HbA1C Testing Product Offered
  • 12.10.3 EKF Diagnostics POC HbA1C Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 EKF Diagnostics News
• 12.11 OSANG Healthcare

13 Research Findings and Conclusion

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.
Asia Pacific is the largest consumption place, with a consumption market share nearly 50.1% in 2017. Following Asia Pacific, North America is the second largest consumption place with the consumption market share of 62.2%

According to this study, over the next five years the POC HbA1C Testing market will register a 6.4% CAGR in terms of revenue, the global market size will reach US$ 560 million by 2024, from US$ 410 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in POC HbA1C Testing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of POC HbA1C Testing market by product type, application, key manufacturers and key regions and countries.

This study considers the POC HbA1C Testing value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Immunoassay
Boronate Affinity
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinics
Diagnostic Laboratories
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Roche
Bio-Rad
Siemens
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
PTS Diagnostics
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global POC HbA1C Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of POC HbA1C Testing market by identifying its various subsegments.
Focuses on the key global POC HbA1C Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the POC HbA1C Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of POC HbA1C Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.